The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors On-Demand Webinar The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…Certara2026 年 7 月 1 日
Beyond compliance: What ICH M15 means for the future of drug development Blog Beyond compliance: What ICH M15 means for the future of drug development Explore how ICH M15 is shaping regulatory expectations for Model-Informed Drug Development (MIDD), including model…Certara2026 年 6 月 9 日
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators On-Demand Webinar The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…Certara2026 年 5 月 26 日
ICH M15 guideline: What the finalized guideline means for model-informed drug development Blog ICH M15 guideline: What the finalized guideline means for model-informed drug development With the release of the draft ICH M15 guidance, MIDD is no longer optional -…Certara2026 年 3 月 18 日
FAQs: The ICH M15 guideline and what it means for model-informed drug development Blog FAQs: The ICH M15 guideline and what it means for model-informed drug development Learn what the ICH M15 guideline means for Model-Informed Drug Development, regulatory credibility, harmonization, and…Certara2026 年 2 月 18 日
Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Guide Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…Certara2026 年 2 月 13 日
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance On-Demand Webinar 模型引导的药物开发(MIDD)的监管环境演变:ICH M15 指南草案的影响 We explore the evolving regulatory landscape for Model-Informed Drug Development (MIDD), focusing on the impact…Certara2025 年 5 月 23 日